Tech Company Financing Transactions
Firefly Bio Funding Round
On 2/15/2024, Firefly Bio raised $94 million in financing from MPM Capital, Versant Ventures and Decheng Capital.
Transaction Overview
Company Name
Announced On
2/15/2024
Transaction Type
Venture Equity
Amount
$94,000,000
Round
Undisclosed
Investors
MPM Capital (Lead Investor)
Versant Ventures (Lead Investor) (Jerel Davis)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Tower Place
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to realize the full potential of ADCs by unlocking new classes of payloads. We have assembled a team of renowned researchers with decades of experience successfully leading the discovery and development of ADCs.?
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Hirsch
Chief Scientific Officer
John Flygare
Chief Technical Officer
Bernhard Geierstanger
Co-Founder
Carolyn Bertozzi
Browse more venture capital transactions:
Prev: 2/14/2024: IPSecure venture capital transaction
Next: 2/15/2024: FreezeM venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs